Antibiotikaprofylax vid kirurgiska ingrepp - SBU

30. Bertrand M, Mangez JF, Choussy O,
Dehesdin D, Marie JP. [Comparison of
two antibioprophylaxis protocols in ear
surgery]. Ann Otolaryngol Chir Cervicofac
2008;125:115-21.
31. Barker E, Pringle M. Survey of prophylactic
antibiotic use amongst UK
cochlear implant surgeons. Cochlear
Implants Int 2008;9:82-9.
32. Hirsch BE, Blikas A, Whitaker M.
Antibiotic prophylaxis in cochlear implant
surgery. Laryngoscope 2007;117:
864-7.
33. Basavaraj S, Najaraj S, Shanks M,
Wardrop P, Allen AA. Short-term versus
long-term antibiotic prophylaxis in
cochlear implant surgery. Otol Neurotol
2004;25:720-2.
34. Blair EA, Johnson JT, Wagner RL,
Carrau RL, Bizakis JG. Cost analysis
of antibiotic prophylaxis in clean head
and neck surgery. Arch Otolaryngol
Head Neck Surg 1995;121:269-71.
35. Gerard M, Meunier F, Dor P, Andry
G, Chantrain G, Van der Auwera P, et
al. Antimicrobial prophylaxis for major
head and neck surgery in cancer patients.
Antimicrob Agents Chemother 1988;32:
1557-9.
36. Mustafa E, Tahsin A. Cefotaxime
prophylaxis in major non-contaminated
head and neck surgery: one-day vs sevenday
therapy. J Laryngol Otol 1993;107:
30-2.
37. Phan M, Van der Auwera P, Andry G,
Aoun M, Chantrain G, Deraemaecker R,
et al. Antimicrobial prophylaxis for major
head and neck surgery in cancer patients:
sulbactam-ampicillin versus clindamycinamikacin.
Antimicrob Agents Chemother
1992;36:2014-9.
38. Bhathena HM, Kavarana NM. Prophylactic
antibiotics administration head
and neck cancer surgery with major flap
reconstruction: 1-day cefoperazone versus
5-day cefotaxime. Acta Chir Plast 1998;
40:36-40.
39. Saginur R, Odell PF, Poliquin JF.
Antibiotic prophylaxis in head and neck
cancer surgery. J Otolaryngol 1988;17:
78-80.
KAPITEL 4 • den systematiska litteraturöversikten
523